NL
AZN icon

Navalign LLC’s AstraZeneca AZN Stock Holding History

Navalign LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Hold
1,312
– – 0.06% 117
2026
Q1 		$259K Sell
1,312
-1
-0.1% -$193 0.07% 111
2025
Q4 		$241K Hold
1,313
– – 0.06% 111
2025
Q3 		$201K Buy
+1,313
New +$199K 0.05% 118
2024
Q4 		– Sell
-1,313
Closed -$205K – 117
2024
Q3 		$205K Hold
1,313
– – 0.06% 118
2024
Q2 		$205K Buy
+1,313
New +$198K 0.06% 109

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Navalign LLC's AZN Position: Q2 2026 in Review

Navalign LLC held its AstraZeneca (AZN) position steady in Q2 2026 at 1,312 shares worth $249K. The position accounts for 0.06% of the portfolio, ranked #117.

Navalign LLC first reported a position in AZN in Q2 2024 and has held it in 6 quarters since. The position peaked at $259K in Q1 2026. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Navalign LLC held 1,312 shares of AstraZeneca worth $249K as of Q2 2026.
  • Navalign LLC left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.06% of Navalign LLC's portfolio in Q2 2026, its #117 holding.
  • Navalign LLC first reported a position in AstraZeneca in Q2 2024 and has held it in 6 quarters since.
  • Navalign LLC's AstraZeneca position peaked at $259K in Q1 2026.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Navalign LLC's 13F filing for Q2 2026, filed 28 Jul 2026.